Scarica l'app Stockscreener
3.66
1.10%
0.04
Dopo l'orario di chiusura:
3.75
0.09
+2.46%
Precedente Chiudi:
$3.62
Aprire:
$3.75
Volume 24 ore:
130.93K
Relative Volume:
0.80
Capitalizzazione di mercato:
$94.93M
Reddito:
$40,000
Utile/perdita netta:
$-38.64M
Rapporto P/E:
-1.9876
EPS:
-1.8414
Flusso di cassa netto:
$-22.21M
1 W Prestazione:
-23.59%
1M Prestazione:
+4.57%
6M Prestazione:
-61.15%
1 anno Prestazione:
-63.14%
Intervallo 1D:
$3.56
$3.78
Intervallo di 1 settimana:
$3.46
$5.195
Portata 52W:
$3.005
$12.99
Neonc Technologies Holdings Inc Stock (NTHI) Company Profile
Nome
Neonc Technologies Holdings Inc
Settore
Industria
Telefono
310 663 7831
Indirizzo
23975 PARK SORRENTO, CALABASAS
Compare NTHI vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NTHI
Neonc Technologies Holdings Inc
|
3.66 | 93.89M | 40,000 | -38.64M | -22.21M | -1.8414 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Neonc Technologies Holdings Inc Stock (NTHI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-05-19 | Iniziato | Alliance Global Partners | Buy |
| 2026-05-18 | Iniziato | Maxim Group | Buy |
| 2026-04-24 | Iniziato | BTIG Research | Buy |
Neonc Technologies Holdings Inc Borsa (NTHI) Ultime notizie
NeOnc raises USD 15m to advance Phase II CNS cancer programs after NEO100 efficacy readout - AllSci
Form 8K Neonc Technologies Holdings Inc For: 10 September By Investing.com - Investing.com India
NeOnc Technologies Launches $15 Million Registered Direct Offering at $4.20 With Warrants - TradingView
NeOnc Technologies Company Profile & Introduction - Moomoo
NeOnc Technologies Holdings Secures $15 Million Registered Direct Offering After Positive Phase 2a Data and Insider Buying - quiverquant.com
NeOnc Raises $15 Million At Market Adding Fuel to the Strong NEO100 Data - marketscreener.com
NeOnc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules with New and Existing Institutional Investors - Stocktwits
NeOnc Technologies prices $15M registered direct offering - Investing.com
NeOnc Technologies prices $15M registered direct offering By Investing.com - Investing.com Canada
NeOnc Technologies Holdings, Inc. Announces Pricing of $15 - GlobeNewswire
symbol__ Stock Quote Price and Forecast - cnn.com
Nearly half had no cancer progression at six months. NeOnc plans to meet U.S. drug regulators. - Stock Titan
NeOnc' Phase 2 Data Could Put Cancer on the Ropes - GlobeNewswire
NeOnc Technologies Holdings Reports Positive NEO100 Phase 2a Results and Prepares for FDA Registrational Pathway Discussion - quiverquant.com
NeOnc’s Phase 2A Success Could Set the Stage for Something Much Bigger - marketscreener.com
NeOnc brain-cancer trial reports 48.9% progression-free at six months, vs. 20% benchmark - Stock Titan
Nature's Miracle Holding (NASDAQ:NTHI): What Could Its Scheduled Update Reveal? - Kalkine Media
NeOnc Technologies Holdings Founder Acquires 1.0% More Stock - Moomoo
ผู้ก่อตั้ง NeOnc Technologies Holdings เข้าซื้อหุ้นเพิ่มอีก 1.0% - Moomoo
NeOnc Technologies (NASDAQ: NTHI) names Shomali to audit panel - Stock Titan
Neonc Technologies CEO Thomas C. Chen acquires $70,010 of common shares via IRA - Bitget
NeOnc Technologies Holds 2026 Annual Stockholder Meeting - The Globe and Mail
Neonc Technologies CEO Thomas Chen buys $69,997 in stock - Investing.com
Neonc Technologies CSO Thomas Chen buys $192,899 in stock - Investing.com
Insider Purchase: CEO of $NTHI Buys 12,757 Shares - Moomoo
NeOnc Technologies (NTHI) CEO adds 12.8K-share IRA stake - Stock Titan
NeOnc Technologies (NTHI) investors approve equity plan, elect two directors - Stock Titan
Founder of NeOnc Technologies Holdings Thomas Chen Buys 1.0% More Shares - simplywall.st
Neonc Technologies CSO Thomas Chen buys $192,899 in stock By Investing.com - Investing.com Canada
NeOnc Technologies- Talk Is Cheap, Insider Buying Isn’t - Sahm
Neonc Technologies CEO Amir Heshmatpour acquires $49,860 in stock By Investing.com - Investing.com India
NeOnc Technologies (NTHI) CEO boosts stake with August open‑market buys - Stock Titan
Neonc Technologies CEO Amir Heshmatpour acquires $49,860 in stock - Investing.com
NeOnc (NTHI) CEO lifts direct stake to 3,096,000 shares - Stock Titan
NeOnc Technologies Holdings CEO Continues Open-Market Buying Following NEO100 Phase 2a Results and Elevated Short Interest - Quiver Quantitative
Neonc Technologies CEO buys $58,579 in company shares By Investing.com - Investing.com Australia
NTHI’s Nasdaq Advantage Takes on New Meaning After Its Breakthrough Phase 2a Results - Sahm
Neonc Technologies CEO buys $58,579 in company shares - Investing.com
NeOnc Technologies (NTHI) CEO adds stock in two August buys - Stock Titan
NeOnc Technologies Holdings, Inc. Common Stock (NASDAQ: NTHI) Stock Price, News & Analysis - Kalkine
Duos Technologies Group Sets Second Quarter 2026 Earnings Call for Monday, August 17, 2026 at 4:30 PM ET - Stocktwits
NeOnc Technologies Holdings' Phase 2a Results Strengthen the Case for Its Nasdaq-Backed Capital Strategy - Moomoo
NeOnc Technologies Holdings’ Phase 2a Results Strengthen the Case for Its Nasdaq-Backed Capital Strategy - Quiver Quantitative
NTHI's Nasdaq Advantage Takes on New Meaning After Its Breakthrough Phase 2a Results - Moomoo
NTHI: All proposals, including director elections and plan amendments, were approved without questions - TradingView
Maxim Group Maintains NeOnc Technologies(NTHI.US) With Buy Rating, Maintains Target Price $20 - Moomoo
The Nose Knows: Why NeOnc’s Patent Portfolio Could Make NTHI More Than a One-Drug Biotech - The Manila Times
NeOnc Reports 26.1-Month Median Overall Survival in Phase 2a Brain Cancer Trial - Minichart
NeOnc Technologies holds investor call to discuss Phase 2a NEO100-01 results By Investing.com - Investing.com Nigeria
Form 8K Neonc Technologies Holdings Inc For: 13 August By Investing.com - Investing.com UK
NeOnc Technologies (NTHI) NEO100 Phase 2a Readout Clears Primary Endpoint, FDA Meeting Planned - kalkine.ca
Neonc Technologies Holdings Inc Azioni (NTHI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):